• Why Bristol-Myers Squibb is making a big bet its approach to treating lung cancer is the right one

    11 monthes ago - By Business Insider

    A new batch of data on Monday showed how immunotherapy, a new kind of cancer treatment that harnesses the body's immune system, works in lung cancer patients.
    Among the data were results on how Bristol-Myers Squibb's combination of two immunotherapy drugs compared to traditional chemotherapy in a certain group of lung cancer patients. While the results were positive, BMS closed on Monday down 7.7%.
    BMS's head of oncology Fouad Namouni told Business Insider why the company's going down a more precise path with its immunotherapy-based combination.
    A new batch of data on Monday showed how...
    Read more ...